Study details
Enrolling now
Acute Equol Supplementation and Vascular Function in Women With and Without CKD
University of Colorado, Denver
NCT IDNCT06128278ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
38
Study length
about 3.8 years
Ages
50–69
Sex
Female only
Locations
1 site in CO
About this study
Researchers are testing whether taking equol, a type of plant compound, improves vascular function in women with and without chronic kidney disease. The trial will measure how equol affects blood vessels after it's taken orally.
Based on ClinicalTrials.gov records.
What participants do
- 1.Placebo
- 2.Take S-equol
PhasePhase 2
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low11%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: Change in Carotid Femoral Pulse Wave Velocity
Body systems
Renal